Subtype Analysis Of The Malignancy-Related Ascites Contributes To Raise Discriminative Ability Of Tumor Markers In Ascites

Yi'An Zhang,Haining Liu,Jimin Zhu,Danying Zhang,Xizhong Shen,Taotao Liu

2016-01-01

Abstract:The discriminative ability of the ascites tumor markers to diagnose malignancy-related ascites has long been controversial. The aim of this study is to establish cut-off values and testify the diagnostic power of ascites CA125, CA19-9 and CEA in the differentiation of non-malignancy and malignancy-related ascites. A retrospective cohort study was conducted and 105 patients with ascites were enrolled and divided into malignancy and nonmalignancy groups. Clinical characteristics were compared and ascites CA125, CA19-9 and CEA were evaluated for their diagnostic capacities via ROC curve analyses. Diagnostic capacities were further evaluated after subset analysis by secretion status of serum tumor markers. Logistic regression was used to build the multi-variate model. Concentrations of ascites CA125, CA19-9 and CEA were higher in malignant than non-malignant group. The AUCs for ascites CA125, CA19-9, CEA and multi-variate model were 0.671, 0.695, 0.802 and 0.799. The diagnostic cutoff value, sensitivity and specificity were 2145 IU/mL, 33.3% and 97.2% for CA125; 78 U/mL, 41.5% and 95.7% for CA19-9; 3.6 IU/mL, 57.6% and 96.1% for CEA; and 1.0, 48.5% and 97.1% for multi-variate model. Subtype analysis showed improved diagnostic capacity for secretory malignancy-related ascites vs. non-malignancy related ascites. The AUCs of ascites CA125, CA19-9, CEA and multi-variate model increased to 0.725, 0.805, 0.903 and 0.901, respectively. Meanwhile, choosing the same cut-off values and specificities yielded higher sensitivities and NPVs for all three tumor markers and the multi-variate model. Subtype analysis of the malignancy-related ascites contributes to raise the discriminative ability of ascites tumor markers.